Vaccine Development Struggles

The urgency for a rubella vaccine surged during a devastating epidemic that infected millions and led to significant complications. Despite initial setbacks with a vaccine using WI 38 cells, determination led to breakthroughs in weakening the virus for effective immunity. However, the overshadowing presence of monkey cell-based vaccines left the promising WI 38 option overlooked, raising concerns about the efficacy of the alternatives.